Cargando…

Efficacy of Neoadjuvant Targeted Therapy for Borderline Resectable III B-D or IV Stage BRAF (V600) Mutation-Positive Melanoma

SIMPLE SUMMARY: Neoadjuvant therapy for locally advanced disease or potentially resectable metastatic melanoma is expected to improve operability and clinical outcomes over upfront surgery. 46 patients were treated with BRAFi/MEKi or BRAFi before surgery with 78% R0 resection. In patients with a maj...

Descripción completa

Detalles Bibliográficos
Autores principales:	Czarnecka, Anna M., Ostaszewski, Krzysztof, Borkowska, Aneta, Szumera-Ciećkiewicz, Anna, Kozak, Katarzyna, Świtaj, Tomasz, Rogala, Paweł, Kalinowska, Iwona, Koseła-Paterczyk, Hanna, Zaborowski, Konrad, Teterycz, Paweł, Tysarowski, Andrzej, Makuła, Donata, Rutkowski, Piotr
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8744603/ https://www.ncbi.nlm.nih.gov/pubmed/35008274 http://dx.doi.org/10.3390/cancers14010110

Ejemplares similares

The Use of ctDNA for BRAF Mutation Testing in Routine Clinical Practice in Patients with Advanced Melanoma
por: Sobczuk, Paweł, et al.
Publicado: (2022)

Efficacy of Sirolimus Treatment in PEComa–10 Years of Practice Perspective
por: Świtaj, Tomasz, et al.
Publicado: (2021)

Systemic Treatment for Advanced and Metastatic Malignant Peripheral Nerve Sheath Tumors—A Sarcoma Reference Center Experience
por: Sobczuk, Paweł, et al.
Publicado: (2020)

Mutation profile of primary subungual melanomas in Caucasians
por: Borkowska, Aneta, et al.
Publicado: (2020)

Efficacy and Safety of Hypofractionated Preoperative Radiotherapy for Primary Locally Advanced Soft Tissue Sarcomas of Limbs or Trunk Wall
por: Koseła-Paterczyk, Hanna, et al.
Publicado: (2021)

Clinicopathological Features and Prognostic Factors of Primary Acral Melanomas in Caucasians
por: Borkowska, Aneta M., et al.
Publicado: (2020)

Hypofractionated Radiotherapy in Locally Advanced Myxoid Liposarcomas of Extremities or Trunk Wall: Results of a Single-Arm Prospective Clinical Trial
por: Koseła-Paterczyk, Hanna, et al.
Publicado: (2020)

The Long-Term Outcomes of Intensive Combined Therapy of Adult Patients with Localised Synovial Sarcoma
por: Kozak, Katarzyna, et al.
Publicado: (2020)

Modern Approach to Melanoma Adjuvant Treatment with Anti-PD1 Immune Check Point Inhibitors or BRAF/MEK Targeted Therapy: Multicenter Real-World Report
por: Placzke, Joanna, et al.
Publicado: (2023)

Feasibility and Long-Term Efficacy of PEComa Treatment—20 Years of Experience
por: Sobiborowicz, Aleksandra, et al.
Publicado: (2021)

Treatment of Locally Advanced Merkel Cell Carcinoma—A Multi-Center Study
por: Dudzisz-Sledz, Monika, et al.
Publicado: (2022)

Comparison of seventh and eighth edition of AJCC staging system in melanomas at locoregional stage
por: Teterycz, Pawel, et al.
Publicado: (2019)

The outcomes of Polish patients with advanced BRAF-positive melanoma treated with vemurafenib in a safety clinical trial
por: Rutkowski, Piotr, et al.
Publicado: (2015)

Predictive Biomarkers of Pathological Response to Neoadjuvant Chemoradiotherapy for Locally Advanced Soft Tissue Sarcomas
por: Szumera-Ciećkiewicz, Anna, et al.
Publicado: (2023)

Multimodal Treatment of Advanced Mucosal Melanoma in the Era of Modern Immunotherapy
por: Teterycz, Pawel, et al.
Publicado: (2020)

Epithelioid Sarcoma—From Genetics to Clinical Practice
por: Czarnecka, Anna M., et al.
Publicado: (2020)

67P Detrimental effect of the COVID-19 pandemic on patients with adult extremity bone sarcoma: Reference center experience
por: Teterycz, P., et al.
Publicado: (2023)

Age as a Prognostic Factor in Patients with Ewing Sarcoma—The Polish Sarcoma Group Experience
por: Jagodzińska-Mucha, Paulina, et al.
Publicado: (2021)

The analysis of the long-term outcomes of sorafenib therapy in routine practice in imatinib and sunitinib resistant gastrointestinal stromal tumors (GIST)*
por: Rutkowski, Piotr, et al.
Publicado: (2017)

The Analysis of Trends in Survival for Patients with Melanoma Brain Metastases with Introduction of Novel Therapeutic Options before the Era of Combined Immunotherapy—Multicenter Italian–Polish Report
por: Placzke, Joanna, et al.
Publicado: (2022)

Trametinib: a MEK inhibitor for management of metastatic melanoma
por: Lugowska, Iwona, et al.
Publicado: (2015)

Gene expression profiling of peripheral blood cells: new insights into Ewing sarcoma biology and clinical applications
por: Przybyl, Joanna, et al.
Publicado: (2014)

Denosumab in Giant Cell Tumor of Bone: Multidisciplinary Medical Management Based on Pathophysiological Mechanisms and Real-World Evidence
por: Borkowska, Aneta Maria, et al.
Publicado: (2022)

Chondrosarcoma-from Molecular Pathology to Novel Therapies
por: Zając, Agnieszka E., et al.
Publicado: (2021)

Current Diagnosis and Treatment Options for Cutaneous Adnexal Neoplasms with Follicular Differentiation
por: Płachta, Iga, et al.
Publicado: (2021)

Current Diagnosis and Treatment Options for Cutaneous Adnexal Neoplasms with Apocrine and Eccrine Differentiation
por: Płachta, Iga, et al.
Publicado: (2021)

Long-Term Outcomes of Targeted Therapy after First-Line Immunotherapy in BRAF-Mutated Advanced Cutaneous Melanoma Patients—Real-World Evidence
por: Rogala, Paweł, et al.
Publicado: (2022)

Treatment of Malignant Adnexal Tumors of the Skin: A 12-Year Perspective
por: Kleibert, Marcin, et al.
Publicado: (2022)

Clinical Significance of Tumor Microenvironment in Acral Melanoma: A Large Single-Institution Study of Caucasians
por: Borkowska, Aneta Maria, et al.
Publicado: (2021)

Analysis of efficacy and safety of vismodegib therapy in patients with advanced basal cell carcinoma – real world multicenter cohort study
por: Słowińska, M., et al.
Publicado: (2022)

Use of extracellular vesicles from lymphatic drainage as surrogate markers of melanoma progression and BRAF(V600E) mutation
por: García-Silva, Susana, et al.
Publicado: (2019)

Dedifferentiated Chondrosarcoma from Molecular Pathology to Current Treatment and Clinical Trials
por: Zając, Weronika, et al.
Publicado: (2023)

Correction: Use of extracellular vesicles from lymphatic drainage as surrogate markers of melanoma progression and BRAF(V600E) mutation
por: García-Silva, Susana, et al.
Publicado: (2019)

Mesenchymal Chondrosarcoma from Diagnosis to Clinical Trials
por: Dudzisz-Śledź, Monika, et al.
Publicado: (2023)

Stereotactic radiotherapy for soft tissue and bone sarcomas: real-world evidence
por: Spałek, Mateusz Jacek, et al.
Publicado: (2022)

Merkel Cell Carcinoma from Molecular Pathology to Novel Therapies
por: Stachyra, Karolina, et al.
Publicado: (2021)

The Role of Pathology-Based Methods in Qualitative and Quantitative Approaches to Cancer Immunotherapy
por: Kuczkiewicz-Siemion, Olga, et al.
Publicado: (2022)

Immune checkpoint inhibitors therapy in older patients (≥ 70 years) with metastatic melanoma: a multicentre study
por: Cybulska-Stopa, Bożena, et al.
Publicado: (2019)

Myocarditis Induced by Immunotherapy in Metastatic Melanoma—Review of Literature and Current Guidelines
por: Czarnecka, Anna M., et al.
Publicado: (2022)

Neoadjuvant Treatment Options in Soft Tissue Sarcomas
por: Spałek, Mateusz Jacek, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_96lo5uer7jfn7dm880pq9pdvjt